B. Olgemöller

983 total citations
27 papers, 713 citations indexed

About

B. Olgemöller is a scholar working on Molecular Biology, Clinical Biochemistry and Surgery. According to data from OpenAlex, B. Olgemöller has authored 27 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Clinical Biochemistry and 7 papers in Surgery. Recurrent topics in B. Olgemöller's work include Metabolism and Genetic Disorders (5 papers), Neurogenetic and Muscular Disorders Research (4 papers) and Neonatal Health and Biochemistry (3 papers). B. Olgemöller is often cited by papers focused on Metabolism and Genetic Disorders (5 papers), Neurogenetic and Muscular Disorders Research (4 papers) and Neonatal Health and Biochemistry (3 papers). B. Olgemöller collaborates with scholars based in Germany, Switzerland and United States. B. Olgemöller's co-authors include A. Roscher, Klaus-Dieter Gerbitz, Erwin Schleicher, Gerd Schmitz, Wolfgang Drobnik, Gerhard Liebisch, Markus Reil, E. Schleicher, Wulf Röschinger and Bernhard Liebl and has published in prestigious journals such as Bioinformatics, Diabetes and Journal of Lipid Research.

In The Last Decade

B. Olgemöller

27 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Olgemöller Germany 16 366 159 105 94 93 27 713
Kayoko Sudo Japan 14 345 0.9× 110 0.7× 105 1.0× 76 0.8× 40 0.4× 35 666
H B Burch United States 13 375 1.0× 104 0.7× 105 1.0× 59 0.6× 179 1.9× 20 731
Hanning You United States 14 494 1.3× 84 0.5× 124 1.2× 101 1.1× 54 0.6× 18 1.1k
Britta Landin Sweden 13 190 0.5× 43 0.3× 80 0.8× 55 0.6× 84 0.9× 31 514
Shigeo Okubo Japan 17 455 1.2× 60 0.4× 145 1.4× 102 1.1× 52 0.6× 42 770
Arno van Rooij Netherlands 12 398 1.1× 207 1.3× 49 0.5× 62 0.7× 21 0.2× 16 630
Chengguo Wei United States 18 453 1.2× 37 0.2× 47 0.4× 110 1.2× 91 1.0× 28 1.1k
Naoaki Murao Japan 15 205 0.6× 45 0.3× 28 0.3× 61 0.6× 59 0.6× 26 624
Kyung Hwan Kim South Korea 8 135 0.4× 71 0.4× 56 0.5× 39 0.4× 43 0.5× 15 672
Mercedes Vázquez–Chantada United Kingdom 14 770 2.1× 73 0.5× 78 0.7× 105 1.1× 105 1.1× 28 1.1k

Countries citing papers authored by B. Olgemöller

Since Specialization
Citations

This map shows the geographic impact of B. Olgemöller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Olgemöller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Olgemöller more than expected).

Fields of papers citing papers by B. Olgemöller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Olgemöller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Olgemöller. The network helps show where B. Olgemöller may publish in the future.

Co-authorship network of co-authors of B. Olgemöller

This figure shows the co-authorship network connecting the top 25 collaborators of B. Olgemöller. A scholar is included among the top collaborators of B. Olgemöller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Olgemöller. B. Olgemöller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller‐Felber, Wolfgang, Katharina Vill, Oliver Schwartz, et al.. (2020). Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening – Opportunity or Burden?. Journal of Neuromuscular Diseases. 7(2). 109–117. 42 indexed citations
2.
Hohenfellner, Katharina, Carsten Bergmann, Tobias Fleige, et al.. (2019). Molecular based newborn screening in Germany: Follow-up for cystinosis. Molecular Genetics and Metabolism Reports. 21. 100514–100514. 24 indexed citations
3.
Vill, Katharina, Astrid Blaschek, Ulrike Schara, et al.. (2017). Spinale Muskelatrophie: Zeit für das Neugeborenenscreening?. Der Nervenarzt. 3 indexed citations
4.
Vill, Katharina, Astrid Blaschek, Ulrike Schara, et al.. (2017). [Spinal muscular atrophy : Time for newborn screening?]. 88(12). 1358–1366. 7 indexed citations
5.
Vill, Katharina, Astrid Blaschek, Ulrike Schara, et al.. (2017). Spinale Muskelatrophie. Der Nervenarzt. 88(12). 1358–1366. 5 indexed citations
6.
Röschinger, Wulf, et al.. (2015). Neue Zielerkrankungen im Neugeborenenscreening. Monatsschrift Kinderheilkunde. 163(2). 142–149. 19 indexed citations
7.
Liebl, Bernhard, Uta Nennstiel, Ulrich Busch, et al.. (2009). Validation of MCADD newborn screening. Clinical Genetics. 76(2). 179–187. 15 indexed citations
8.
9.
Baumgärtner, Christian, Christian Böhm, Daniela Baumgartner, et al.. (2004). Supervised machine learning techniques for the classification of metabolic disorders in newborns. Bioinformatics. 20(17). 2985–2996. 58 indexed citations
10.
Ehrenstein, Ondine S. von, Erika von Mutius, Esther M. Maier, et al.. (2002). Lung function of school children with low levels of α1-antitrypsin and tobacco smoke exposure. European Respiratory Journal. 19(6). 1099–1106. 26 indexed citations
11.
Liebl, Bernhard, Ralph Fingerhut, Wulf Röschinger, et al.. (2000). Modellprojekt zur Neuordnung des Neugeborenen-Screenings in Bayern: Konzeption und erste Ergebnisse. Das Gesundheitswesen. 62(4). 189–195. 13 indexed citations
12.
Rolinski, Boris, Torsten Dame, B. Olgemöller, et al.. (2000). The biochemical metabolite screen in the Munich ENU Mouse Mutagenesis Project: determination of amino acids and acylcarnitines by tandem mass spectrometry. Mammalian Genome. 11(7). 547–551. 20 indexed citations
13.
Liebisch, Gerhard, Wolfgang Drobnik, Markus Reil, et al.. (1999). Quantitative measurement of different ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESI-MS/MS). Journal of Lipid Research. 40(8). 1539–1546. 224 indexed citations
14.
Gempel, Klaus, Klaus-Dieter Gerbitz, B. Olgemöller, & E. Schleicher. (1993). In-Vitro Carboxymethylation of Low Density Lipoprotein Alters its Metabolism Via the High-Affinity Receptor. Hormone and Metabolic Research. 25(5). 250–252. 14 indexed citations
15.
Schleicher, Erwin & B. Olgemöller. (1992). Glomerular changes in diabetes mellitus.. PubMed. 30(10). 635–40. 14 indexed citations
16.
Olgemöller, B., et al.. (1990). Competitive inhibition by glucose of myo-inositol incorporation into cultured porcine aortic endothelial cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1052(1). 47–52. 25 indexed citations
17.
Olgemöller, B., et al.. (1990). Differential kinetics of glucose metabolism in porcine retinal and aortic endothelial cells.. PubMed. 28(1). 15–7. 5 indexed citations
18.
Olgemöller, B., et al.. (1989). Characterization and localization of basement membrane-associated heparan sulfate proteoglycan in human tissues.. PubMed. 61(3). 323–32. 32 indexed citations
19.
Olgemöller, B., E. Schleicher, Michael Nerlich, Elizabeth M. Wagner, & Klaus-Dieter Gerbitz. (1989). Isolation, Characterization and Immunological Determination of Basement Membrane-Associated Heparan Sulfate Proteoglycan. Biological Chemistry Hoppe-Seyler. 370(2). 1321–1330. 18 indexed citations
20.
Olgemöller, B., E. Schleicher, Tony Durst, & O. Wieland. (1984). Sensitive measurement of lipoprotein degradation by cell cultures using HPLC. Fresenius Zeitschrift für Analytische Chemie. 317(6). 709–709. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kayoko Sudo Breakdown of academic impact, for papers by H B Burch Breakdown of academic impact, for papers by Hanning You Breakdown of academic impact, for papers by Britta Landin Breakdown of academic impact, for papers by Shigeo Okubo Breakdown of academic impact, for papers by Arno van Rooij Breakdown of academic impact, for papers by Chengguo Wei Breakdown of academic impact, for papers by Naoaki Murao Breakdown of academic impact, for papers by Kyung Hwan Kim Breakdown of academic impact, for papers by Mercedes Vázquez–Chantada
Rankless by CCL
2026